No ingenious post full of DD and mathematical analysis, not smart enough… but I found this.
Posts recently about 29% yearly gains requiring close observation and intricate trading of 5 different food companies. It received sceptical responses.
Small cap biotech, that's the companies building new medicines from scratch, one could argue the only industry on earth that truly cannot be disrupted with trillions of dollars, is reasonably well represented by the ETF ticker symbol XBI.
If, over the last decade, you simply bought XBI at $65 and sold at $90, you'd be at 7x the initial investment (including divs), trouncing… well basically every index I follow, except a squeaker loss to SMH.
Just sayin'.
Leave a Reply